Target intelligence / Profile preview

Multiple Coagulation Factor Deficiencies (MCFDs)

Target
MCFDs
Molecular classification
Enzyme, Serine protease, Glycoprotein, Transglutaminase
01

Overview

Multiple coagulation factor deficiencies (MCFDs) are rare inherited bleeding disorders characterized by the simultaneous deficiency or dysfunction of two or more blood coagulation factors. These factors are essential proteins involved in the coagulation cascade, which leads to blood clot formation. MCFDs can arise from coincidental inheritance of single-factor deficiencies, single-gene defects affecting multiple factors, or chromosomal deletions. Diagnosis involves clotting assays and molecular genetic testing. Treatment typically involves replacement therapy with plasma-derived or recombinant coagulation factors.

Other names
Familial Multiple Coagulation Factor DeficienciesFMCFDsCombined coagulation factor deficiency
02

Mechanism of action

Replacement of deficient coagulation factors, modulation of coagulation pathways (indirectly)

03

Biological functions

Blood clot formationHemostasisCoagulation cascade
04

Disease associations

Bleeding disorders
05

Safety considerations

Thrombotic complications (with excessive replacement)Development of inhibitors against replacement factorsTransfusion-related reactions (with plasma-derived products)
06

Interacting drugs

Plasma-derived coagulation factors

2 more in the full profile.

07

Biomarkers

PT/INRPTT/aPTTFactor V activityFactor VIII activitySpecific coagulation factor activity levelsGenetic mutations in coagulation factor genes

Beyond the preview

Go deeper on Multiple Coagulation Factor Deficiencies (MCFDs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple Coagulation Factor Deficiencies (MCFDs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call